Navigation Links
Calvert Research Licenses Novel Technology to Treat Age Related Macular Degeneration from Tulane University
Date:6/10/2009

ness, law, liberal arts, medicine, public health and tropical medicine, the sciences and engineering, and social work.

About Calvert Research, LLC:
Established in early 2005 to work with early-stage biotechnology companies to advance their lead drug candidates, Calvert Research has further evolved to working closely with Technology Transfer executives of major universities across the country to identify, license, and develop novel compounds and technology platforms in a variety of disease areas.

About Calvert Holdings, Inc.:
Formed in 1996, Calvert Holdings, Inc. (www.calvertholdings.com) is a privately-held company consisting of a diverse portfolio of companies including the following: Calvert Laboratories, Inc.; Calvert Research, LLC; Calvert Creative, LLC; Carolina Securities, Inc. and Calvert Cafe.

Calvert Holdings is a company of people who are passionately engaged in contributing to the future well being of the planet we live on. By analyzing how emerging discoveries and current trends will affect future global needs, we position resources and apply our skills to meet them.

###

Read the full story at http://www.prweb.com/releases/2009/06/prweb2512974.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. Calvert Research and Auburn University Announce Joint Venture
2. Calvert Labs Announces the Hiring of Terry Ladd
3. Calvert Research and CureDM Sign Collaborative Agreement
4. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
5. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
6. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
7. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
8. Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
9. eResearchTechnology to Present at the Thomas Weisel Healthcare Conference 2007 on September 5th
10. The Debiopharm Life Sciences Award Goes to Dr Nusser for his Outstanding Research in Neuroscience
11. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Calvert Research Licenses Novel Technology to Treat Age Related Macular Degeneration from Tulane University
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
... (Nasdaq: MATK ) announced today that it will ... Pharmaceuticals Conference in,London. The conference is being held May ... Steve Dubin, CEO will be presenting on Wednesday,May 28, ... Interested parties may access a live audio webcast ...
... the news release, "Rosetta Genomics Reports First Quarter 2008,Financial ... Rosetta Genomics Ltd,nasdaq:ROSG over PR Newswire, we are advised ... the conference call, as stated beneath the header,Conference Call ... ET,as previously issued. Complete, corrected release follows:, , ...
... YORK, May 21 Citing increasing demand for a ... Dr. Lance H. Brown has expanded his Manhattan practice ... His telephone number,there is 631-725-1771., As summer draws ... of too many seasons in the sun. Those seeking ...
Cached Biology Technology:/C O R R E C T I O N -- Rosetta Genomics Ltd/ 2/C O R R E C T I O N -- Rosetta Genomics Ltd/ 3/C O R R E C T I O N -- Rosetta Genomics Ltd/ 4/C O R R E C T I O N -- Rosetta Genomics Ltd/ 5/C O R R E C T I O N -- Rosetta Genomics Ltd/ 6/C O R R E C T I O N -- Rosetta Genomics Ltd/ 7/C O R R E C T I O N -- Rosetta Genomics Ltd/ 8/C O R R E C T I O N -- Rosetta Genomics Ltd/ 9/C O R R E C T I O N -- Rosetta Genomics Ltd/ 10/C O R R E C T I O N -- Rosetta Genomics Ltd/ 11/C O R R E C T I O N -- Rosetta Genomics Ltd/ 12/C O R R E C T I O N -- Rosetta Genomics Ltd/ 13/C O R R E C T I O N -- Rosetta Genomics Ltd/ 14/C O R R E C T I O N -- Rosetta Genomics Ltd/ 15/C O R R E C T I O N -- Rosetta Genomics Ltd/ 16/C O R R E C T I O N -- Rosetta Genomics Ltd/ 17/C O R R E C T I O N -- Rosetta Genomics Ltd/ 18/C O R R E C T I O N -- Rosetta Genomics Ltd/ 19/C O R R E C T I O N -- Rosetta Genomics Ltd/ 20Board Certified Dermatologist and President-Elect of the Dermatologic Society of Greater New York, Dr. Lance H. Brown Takes His Comprehensive Practice to East Hampton, NY 2
(Date:12/17/2014)... 16, 2014  Automation is fundamentally transforming the ... than at international borders. Over the past decade, ... allowed veteran travelers to self process through border ... Kiosks at an increasing number of airports, seaports, ... According to Maxine Most , Principal ...
(Date:12/11/2014)... 10, 2014  That blood pressure plays a role in ... – the medical term for high blood pressure – was ... the inflatable cuff that,s used in measuring blood pressure was ... nothing new about hypertension, its triggers and its effects. In ... condition and the best ways to treat it. ...
(Date:12/10/2014)... 2014  Wake Forest Baptist Medical Center today announced plans ... of Medicine. Funding for this $50 million capital project ... be publicly launched next summer. The ... 60 series R.J. Reynolds Tobacco Company complex, adjacent to ... immediately with plans to be ready to welcome medical ...
Breaking Biology News(10 mins):Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
... Graeme Ian Bell, PhD, the Louis Block Distinguished Service ... in the Kovler Diabetes Center at the University of ... for 2012 for his pioneering work in understanding the ... diabetes. The prize, the world,s largest award ...
... Mak Saito, a biogeochemist at Woods Hole Oceanographic Institution, has ... by the Gordon and Betty Moore Foundation. Saito is one ... funds from a total of up to $35 million over ... marine microbial ecology. "We are grateful to the Moore ...
... Wilmington, DE This month, Molecular Pharmaceutics ... for Childhood Cancer Research and the Materials Science ... about the potential for nanotechnology to deliver chemotherapeutic ... without harming healthy cells. To date, nanoparticle-based drug ...
Cached Biology News:University of Chicago's Graeme Bell receives international diabetes prize 2University of Chicago's Graeme Bell receives international diabetes prize 3WHOI scientist receives marine microbiology initiative investigator award from Moore Foundation 2Nanotechnology drug delivery shows promise for treatment of pediatric cancer 2
... (6-28) (human, bovine, porcine, rat) ... (VIP) receptor antagonist. This carboxy-terminal ... be twofold more potent than ... antagonists. Storage: ...
Protein 3D structure prediction, via threading. Easy to use....
L1 Protein of Human Papilloma Virus Purified Anti-Viral-transformed cells clone CAMVIR-1, Isotype Mouse IgG 2a , 0.1 mg Consult technical datasheet for details....
ANTI 5-HYDROXYTRYPTOPHAN CONJ....
Biology Products: